老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Can-Fite Biopharma Ltd

2.33
+0.17007.87%
盤後：2.330.00000.00%19:54 EDT
成交量：15.50萬
成交額：35.41萬
市值：499.21萬
市盈率：-0.50
高：2.37
開：2.17
低：2.16
收：2.16
52周最高：13.40
52周最低：2.16
股本：214.25萬
流通股本：214.25萬
量比：0.95
換手率：7.23%
股息：- -
股息率：- -
每股收益(TTM):-4.6460
每股收益(LYR):-1,791.0249
淨資產收益率：-211.37%
總資產收益率：-77.12%
市淨率：1.03
市盈率(LYR):0.00

資料載入中...

總覽公司新聞公告
2020/02/20

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/11

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/10

[修訂]招股説明書

[Amend] Registration statement for certain foreign private issuers
2020/02/07

SEC問詢函

CORRESP [Cover] - Correspondence
2020/02/07

SEC問詢函

CORRESP [Cover] - Correspondence
2020/02/07

SEC問詢函

CORRESP [Cover] - Correspondence
2020/02/04

SEC問詢函

CORRESP [Cover] - Correspondence
2020/02/04

SEC問詢函

CORRESP [Cover] - Correspondence
2020/02/03

[修訂]招股説明書

[Amend] Registration statement for certain foreign private issuers
2020/02/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/31

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/24

招股説明書

Registration statement for certain foreign private issuers
2020/01/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多